Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05183035
Title Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors LLS PedAL Initiative, LLC
Indications

acute myeloid leukemia

Therapies

Azacitidine + Cytarabine + Fludarabine + Gemtuzumab ozogamicin + Venetoclax

Azacitidine + Cytarabine + Fludarabine + Gemtuzumab ozogamicin

Age Groups: child | adult
Covered Countries USA

Additional content available in CKB BOOST